Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Profiling Systems Awarded Biowarfare SBIR

NEW YORK, May 19 - Bedford, Mass.-based diagnostic firm Genomic Profiling Systems has received a $119,820 Phase I Small Business Innovation Research Grant from the National Institutes of Health to develop its MultiPath test for the rapid detection of biological warfare agents, the company said today.

 

The grant, awarded by the National Institute of Allergy and Infectious Disease, will support commercializaton of the company's technology, which uses high-intensity, target-specific microbead labels in combination with instant film imaging. According to the company, individual microbial cells labeled with the beads are easily visible on instant film.

 

The company said that a commercial version of the quantitative test would be able to scan for agents such as anthrax, smallpox, and botulinum toxin at levels below what other rapid test methods detect.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.